Molecular epidemiology, spike-protein evolution, antigenic variation, and experimental pathogenicity of G2c porcine epidemic diarrhea virus: a systematic review

Cliometrica · Springer Nature · 2026-11-13 · DOI: 10.1007/s11259-026-11634-1

Аннотация

Porcine epidemic diarrhea virus (PEDV) is a major cause of severe enteric disease and mortality in neonatal piglets. This systematic review aimed to synthesize current evidence on the molecular epidemiology, spike-protein variation, experimental pathogenicity, and control-related applications of the G2c lineage. Web of Science Core Collection, PubMed, and ScienceDirect were searched for peer-reviewed original studies published from 1 January 2020 to 31 May 2026. Of 78 records identified, 26 studies met the eligibility criteria. G2c was the most frequently assigned lineage in several national, multi-provincial, and regional PEDV datasets in China, particularly in Sichuan and Guangdong. However, its distribution was geographically heterogeneous, and G2a remained predominant in Guangxi. Contemporary G2c viruses exhibited extensive spike-protein variation, including substitutions, insertions, deletions, and predicted glycosylation changes in antigenically relevant regions. Cross-neutralization studies demonstrated strain-dependent antigenic differences, but consistent lineage-wide immune escape was not established. Experimental infections showed that natural G2c isolates caused acute watery diarrhea, dehydration, intestinal villous atrophy, high viral shedding, and, in some studies, substantial mortality in neonatal or suckling piglets. Heterogeneity in experimental design prevented reliable comparison of virulence among strains. Current evidence also supports the development of G2c-specific molecular diagnostics and several vaccine approaches, including cell-adapted candidates, maternal-immunity strategies, messenger RNA vaccines, and autogenous inactivated vaccines. Overall, G2c is an epidemiologically important and pathogenic PEDV lineage. Standardized classification, whole-genome surveillance, functional antigenic studies, matched challenge experiments, and heterologous vaccine-efficacy evaluations are needed to improve disease control.

Читать у издателя →

Похожие статьи